This is a synthetic peptide designed for use in combination with anti-Vgll2 Antibody(ARP37509_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
VGLL2
Reaktivität: Maus, Human, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
VGLL2
(Vestigial Like 2 (VGLL2))
Synonyme
VGL2 Peptide, VITO1 Peptide, vgll2a Peptide, MGC114146 Peptide, zgc:114146 Peptide, C130057C21Rik Peptide, VITO-1 Peptide, Vito1 Peptide, vgl-2 Peptide, zgc:110098 Peptide, vestigial like family member 2 Peptide, vestigial-like family member 2 Peptide, vestigial-like family member 2a Peptide, vestigial like family member 2 L homeolog Peptide, vestigial-like family member 2b Peptide, VGLL2 Peptide, Vgll2 Peptide, vgll2a Peptide, vgll2.L Peptide, vgll2b Peptide
Hintergrund
Vgll2 may act as a specific coactivator for the mammalian TEFs. May play a role in the development of skeletal muscles.